Long‐term delirium and survival outcomes in patients treated with GLP‐1 receptor agonists versus metformin in type 2 diabetes: A population‐based cohort study

Abstract Aim Type 2 diabetes mellitus (T2DM) is associated with an increased risk of delirium and mortality. While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) provide metabolic and neuroprotective benefits, their long-term impact on delirium risk remains uncertain. This study compares GLP-1 RAs and metformin in relation to delirium and mortality in T2DM patients using real-world … Read more

I lost 5st on Mounjaro & did zero exercise – it took me from unhappy & overweight to finally being confident in 7 months

A MOTHER has revealed that she was unhappy and overweight so decided to start using Mounjaro. In just seven months, thanks to the injections, Claire Walton was able to lose five stone. A mother went from unhappy and overweight to slender and confident thanks to MounjaroTiktok/@clairewalton21 Tiktok/@clairewalton21Claire Walton not only dropped five stone whilst using … Read more

Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

One day after WeightWatchers said that it would file for bankruptcy, weight-loss drug giant Novo Nordisk’s outlook is brightening. Novo Nordisk, the Danish company that produces semaglutide drugs Ozempic and Wegovy, saw its shares rise more than 7% Wednesday, in spite of recent headwinds from widely available copycat versions of its signature weight-loss drugs.  Following … Read more

Weight Watchers Goes Bankrupt After Rise of Ozempic-Like Drugs

Ozempic and other drugs like it have been threatening the established diet industry since they premiered — and it appears that Weight Watchers is now getting the hatchet. In a note to investors, the long-running weight loss company is taking the “strategic action” of filing for bankruptcy in hopes of consolidating its immense $1.15 billion … Read more

Weightwatchers files for bankruptcy as Ozempic and Mounjaro surge in popularity – BBC

Weightwatchers files for bankruptcy as Ozempic and Mounjaro surge in popularity  BBC WeightWatchers Files Bankruptcy to Adapt to Chemically Induced Weight-Loss Future  WSJ WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt  The New York Times WeightWatchers goes bankrupt, as offering GLP-1 drugs couldn’t cure its debt problems  MarketWatch WeightWatchers files for bankruptcy  CNN